Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 644-652

  Wang, Xueqian ^a   Hawkins, Brian T ^a,b   Miller, David S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Brain capillaries; Breast cancer resistance protein; Dioxin; Multidrug resistance associated protein 2; P glycoprotein

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ADENOSINE TRIPHOSPHATE; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BREAST CANCER RESISTANCE PROTEIN; CYCLOHEXIMIDE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DACTINOMYCIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; RESVERATROL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN PERFUSION; CONTROLLED STUDY; DRUG BRAIN LEVEL; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SYSTEMATIC REVIEW; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD-BRAIN BARRIER; CARRIER PROTEINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; UP-REGULATION; XENOBIOTICS;

RATTUS;

EID: 79551639774     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-169227     Document Type: Article

References (50)

1. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R., and Begley, D. J. (2009) Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25
2. Miller, D. S. (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246-254
3. Bauer, B., Yang, X., Hartz, A. M., Olson, E. R., Zhao, R., Kalvass, J. C., Pollack, G. M., and Miller, D. S. (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol. Pharmacol. 70, 1212-1219
4. Rigor, R. R., Hawkins, B. T., and Miller, D. S. (2010) Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain. J. Cereb. Blood Flow Metab. 30, 1373-1383
5. White, S. S., and Birnbaum, L. S. (2009) An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27, 197-211
6. Deng, L., Lin-Lee, Y. C., Claret, F. X., and Kuo, M. T. (2001) 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-κB pathway. J. Biol. Chem. 276, 413-420
7. Granberg, L., Ostergren, A., Brandt, I., and Brittebo, E. B. (2003) CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz (a) anthracene in endothelial cells. Drug Metab. Dispos. 31, 259-265
8. Jigorel, E., Le Vee, M., Boursier-Neyret, C., Parmentier, Y., and Fardel, O. (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 34, 1756-1763
9. Han, Y., and Sugiyama, Y. (2006) Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice. Biol. Pharm. Bull. 29, 1032-1035
10. Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas-Duport, C., Couraud, P. O., Scherrmann, J. M., De Waziers, I., and Decleves, X. (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J. Neurochem. 107, 1518-1528
11. Dauchy, S., Miller, F., Couraud, P. O., Weaver, R. J., Weksler, B., Romero, I. A., Scherrmann, J. M., De Waziers, I., and Decleves, X. (2009) Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol. 77, 897-909
12. Schramm, U., Fricker, G., Wenger, R., and Miller, D. S. (1995) P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am. J. Physiol. Renal Physiol. 268, F46-F52
13. Allen, J. D., van Loevezijn, A., Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H., Koomen, G. J., and Schinkel, A. H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417-425
14. Hartz, A. M., Bauer, B., Fricker, G., and Miller, D. S. (2004) Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol. Pharmacol. 66, 387-394
15. Miller, D. S., Nobmann, S. N., Gutmann, H., Toeroek, M., Drewe, J., and Fricker, G. (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58, 1357-1367
16. Bauer, B., Hartz, A. M., Lucking, J. R., Yang, X., Pollack, G. M., and Miller, D. S. (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J. Cereb. Blood Flow Metab. 28, 1222-1234
17. Shukla, S., Zaher, H., Hartz, A., Bauer, B., Ware, J. A., and Ambudkar, S. V. (2009) Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm. Res. 26, 480-487
18. Joiakim, A., Mathieu, P. A., Palermo, C., Gasiewicz, T. A., and Reiners, J. J., Jr. (2003) The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor. Drug Metab. Dispos. 31, 1279-1282
19. Minsavage, G. D., Park, S. K., and Gasiewicz, T. A. (2004) The aryl hydrocarbon receptor (AhR) tyrosine 9, a residue that is essential for AhR DNA binding activity, is not a phosphoresidue but augments AhR phosphorylation. J. Biol. Chem. 279, 20582-20593
20. Hawkins, B. T., Sykes, D. B., and Miller, D. S. (2010) Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. J. Neurosci. 30, 1417-1425
21. Gasiewicz, T. A., and Bauman, P. A. (1987) Heterogeneity of the rat hepatic Ah receptor and evidence for transformation in vitro and in vivo. J. Biol. Chem. 262, 2116-2120
22. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195
23. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., and Savouret, J. F. (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 56, 784-790
24. Wilhelmsson, A., Whitelaw, M. L., Gustafsson, J. A., and Poellinger, L. (1994) Agonistic and antagonistic effects of alpha-naphthoflavone on dioxin receptor function. Role of the basic region helix-loop-helix dioxin receptor partner factor Arnt. J. Biol. Chem. 269, 19028-19033
25. Santostefano, M., Merchant, M., Arellano, L., Morrison, V., Denison, M. S., and Safe, S. (1993) alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol. Pharmacol. 43, 200-206
26. Harrigan, J. A., McGarrigle, B. P., Sutter, T. R., and Olson, J. R. (2006) Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol. In Vitro 20, 426-438
27. Drahushuk, A. T., McGarrigle, B. P., Tai, H. L., Kitareewan, S., Goldstein, J. A., and Olson, J. R. (1996) Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol. 140, 393-403
28. Klaassen, C. D., and Aleksunes, L. M. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol. Rev. 62, 1-96
29. Hartz, A. M., Miller, D. S., and Bauer, B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol. Pharmacol. 77, 715-723
30. Ko, H. P., Okino, S. T., Ma, Q., and Whitlock, J. P., Jr. (1996) Dioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structure. Mol. Cell. Biol. 16, 430-436
31. Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., and Dalton, T. P. (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59, 65-85
32. Johnson, D. R., and Klaassen, C. D. (2002) Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol. Sci. 67, 182-189
33. Smith, Q. R., and Allen, D. D. (2003) In situ brain perfusion technique. Methods Mol. Med. 89, 209-218
34. Dagenais, C., Zong, J., Ducharme, J., and Pollack, G. M. (2001) Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds. Pharm. Res. 18, 957-963
35. De Klerk, O. L., Bosker, F. J., Willemsen, A. T., van Waarde, A., Visser, A. K., de Jager, T., Dagyte, G., den Boer, J. A., Dierckx, R. A., and Meerlo, P. (2009) Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the bloodbrain barrier: an experimental PET study in rats. J. Psychopharmacol 24, 1237-1242
36. Kainu, T., Gustafsson, J. A., and Pelto-Huikko, M. (1995) The dioxin receptor and its nuclear translocator (Arnt) in the rat brain. Neuroreport 6, 2557-2560
37. Filbrandt, C. R., Wu, Z., Zlokovic, B., Opanashuk, L., and Gasiewicz, T. A. (2004) Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25, 605-616
38. Mandal, P. K. (2005) Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. B 175, 221-230
39. Bertazzi, P. A., Bernucci, I., Brambilla, G., Consonni, D., and Pesatori, A. C. (1998) The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 106(Suppl. 2), 625-633
40. Hong, S. J., Grover, C. A., Safe, S. H., Tiffany-Castiglioni, E., and Frye, G. D. (1998) Halogenated aromatic hydrocarbons suppress CA1 field excitatory postsynaptic potentials in rat hippocampal slices. Toxicol. Appl. Pharmacol. 148, 7-13
41. Collins, L. L., Williamson, M. A., Thompson, B. D., Dever, D. P., Gasiewicz, T. A., and Opanashuk, L. A. (2008) 2,3,7,8-Tetracholorodibenzo-p- dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum. Toxicol. Sci. 103, 125-136
42. Nayyar, T., Zawia, N. H., and Hood, D. B. (2002) Transplacental effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the temporal modulation of Sp1 DNA binding in the developing cerebral cortex and cerebellum. Exp. Toxicol. Pathol. 53, 461-468
43. Seelbach, M., Chen, L., Powell, A., Choi, Y. J., Zhang, B., Hennig, B., and Toborek, M. (2010) Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation. Environ. Health Perspect. 118, 479-484
44. Mathieu, M. C., Lapierre, I., Brault, K., and Raymond, M. (2001) Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator-and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo-(a)pyrene in hepatoma cells. J. Biol. Chem. 276, 4819-4827
45. Agarwal, S., Sane, R., Gallardo, J. L., Ohlfest, J. R., and Elmquist, W. F. (2010) Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux. J. Pharmacol. Exp. Ther. 334, 147-155
46. Chen, Y., Agarwal, S., Shaik, N. M., Chen, C., Yang, Z., and Elmquist, W. F. (2009) P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib. J. Pharmacol. Exp. Ther. 330, 956-963
47. Geyer, J., Gavrilova, O., and Petzinger, E. (2009) Brain penetration of ivermectin and selamectin in mdr1a, b P-glycoproteinand bcrp-deficient knockout mice. J. Vet. Pharmacol. Ther. 32, 87-96
48. Noguchi, K., Katayama, K., Mitsuhashi, J., and Sugimoto, Y. (2009) Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug Deliv. Rev. 61, 26-33
49. Zhou, S. F., Wang, L. L., Di, Y. M., Xue, C. C., Duan, W., Li, C. G., and Li, Y. (2008) Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 15, 1981-2039
50. Wang, X., Sykes, D. B., and Miller, D. S. (2010) Constitutive androstane receptor-mediated upregulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol. Pharmacol. 78, 376-383